Morpholine Related Application Product Tirofiban hydrochloride

Tirofiban hydrochloride

  Post Date: Dec 07,2021
  Expiry Date: Jun 05,2022
  Detailed Description: Cas No. :150915-40-5;142373-60-2 Tirofiban hydrochloride
150915-40-5

  CAS Registry Number:

150915-40-5;142373-60-2

  Synonyms: ;n-(butylsulfonyl)-o-[4-(4-piperidynyl)butyl]-l-tyrosine hydrochloride monohydrate;(2s)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic acid hydrochloride monohydrate;n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-l-tyrosine hydrochloride monohydrate;n-butylsulfonyl-o-(4-(4-pyridinyl)butyl)-l-tyrosine hydrochloride monohydrate;n-(butylsulfonyl)-o-[4-pyridin-4-yl]butyl]-l-tyrosine hydrochloride monohydrate;(2R)-3-(butylsulfonyl)-2-{4-[4-(piperidin-4-yl)butoxy]benzyl}propanoic acid hydrochloride hydrate;Tirofiban HCl monohydrate;Tirofiban hydrochloride;n-(butylsulfonyl)-o-[4-(4-piperidynyl)butyl]-l-tyrosine hydrochloride;(2s)-2-(butylsulfonylamino)-3-[4-[4-(4-piperidyl)butoxy]phenyl]propanoic acid hydrochloride;n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-l-tyrosine hydrochloride;n-butylsulfonyl-o-(4-(4-pyridinyl)butyl)-l-tyrosine hydrochloride;n-(butylsulfonyl)-o-[4-pyridin-4-yl]butyl]-l-tyrosine hydrochloride;N-(butylsulfonyl)-O-[4-(piperidin-4-yl)butyl]-L-tyrosine hydrochloride hydrate;N-(butylsulfonyl)-O-[4-(piperidin-4-yl)butyl]-L-tyrosine hydrochloride (1:1);1-[3-(2,4,6-Trimethoxybenzoyl)propyl]pyrrolidinium chloride;Tirofiban HCL;
  Molecular Formula: C23H40ClNO6S
  Molecular Weight: 494.0848
  Molecular Structure: 150915-40-5;142373-60-2 Tirofiban hydrochloride monohydrate

This article is from the internet and does not represent Morpholine position. Please indicate the source when reprinting.https://www.51dmapa.com/tirofiban-hydrochloride-2/

author:

Previous article
Next article
Contact Us

Contact us

+86 - 183 0190 3151

Online consultation: QQ交谈

E-mail: info@newtopchem.com

Working hours: Monday to Friday, 9:00-17:30, closed on holidays
Follow wechat
Scan wechat and follow us

Scan wechat and follow us